TRADING UPDATES: Wellnex extends Haleon deal; Crimson Tide wins deals
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
----------
Wellnex Life Ltd - Melbourne-based consumer healthcare products company - Signs extension to the existing licensing and supply agreement with Haleon PLC and Olive Pharmascience Ltd. The deal is for the supply of soft gel liquid paracetamol products and it has been extended to March 2027.
----------
Crimson Tide PLC - Turnbridge Wells, England-based field management software provider - Crimson Tide wins three new deals, which represent a combined monthly recurring revenue of around £8,300. ‘The three contracts span the company’s core verticals of food safety, retail and facilities management, and include a new customer win in the United States, further demonstrating the breadth and momentum of its commercial pipeline,’ Crimson Tide says.
----------
Catenai PLC - London-based technology and digital services company specialising in data management, security, and compliance - Investee Alludium Ltd gets ISO 27001:2022 certification and SOC 2 Type II attestation, milestones that enhance its ‘potential to sell to enterprise clients’.
----------
Sundae Bar PLC - operator of a unified marketplace for artificial intelligence agents - Its sundae_bar has delivered multiple enterprise AI agents, achieving $10,000 of revenue from the deployments. ‘This marks continued commercial progress in live business workflows and is consistent with its stated aim of becoming revenue generating within 12 months admission,’ the firm adds.
----------
Mind Gym PLC - London-based personal and business coaching service - Mind Gym says it saw a stronger performance in the second half than the first. ‘Along with a number of significant contract opportunities slipping into Q1 FY27, this should provide positive momentum for the new financial year, notwithstanding the challenging global macroeconomic conditions,’ it adds. For the year to March 31, it expects to report revenue of £29.7 million, down 8% on the year prior. Adjusted earnings before interest, tax, depreciation, and amortisation of £600,000 is expected, down from £1.9 million, but it would signify a return to profit in the second half, after a £1 million loss in the first.
----------
BP Marsh & Partners PLC - investor in early-stage financial services businesses - Acquires additional 2% stake in Pantheon Specialty Group Ltd, based on a valuation of £275 million. The holding, bought from founders Robert Dowman and Michael Lee, takes BP Marsh’s stake to 41%. The firm says: ‘Originally launched in 2023 with a primary focus on Global Casualty and Professional Lines, Pantheon has since developed as a full-service London market wholesale insurance broker, having built out the following specialisms: Marine, Global Property, Innovation & Technology, and Delegated Authorities across multiple disciplines. Pantheon has delivered strong growth and established itself as a high-quality, scalable specialty insurance broking platform, underpinned by an experienced leadership team and long-standing client relationships.’
----------
Maven Renovar VCT PLC - invests in AIM-traded companies - Proposes a tender offer as well a change to its investing policy. The tender offer move came after a shareholder consultation exercise. Maven Renovar says a conclusion reached in a strategic review is that an ‘AIM Plus’ investing strategy would be in its interests. This would ‘le a greater degree of investment in unquoted companies’. ‘The board intends to seek shareholder approval in respect of the proposed amendments to the company’s investment objectives and policy at the 2026 AGM. While a majority of respondents to the shareholder survey indicated that they would be supportive of changes to the company’s investment policy to adopt an ’AIM Plus’ strategy, other respondents indicated that they were neutral or would not support the proposal without further information,’ the venture capital trust says. ‘While the board continues to believe that the adoption of an ’AIM Plus‘ strategy is in the best interests of shareholders as a whole, the board recognises that some shareholders may wish to realise part, or potentially all, of their shareholding. In order that such shareholders will have the opportunity to do so prior to the ’AIM Plus‘ strategy potentially being adopted by the company following approval by shareholders at the 2026 AGM, the company intends to put forward a tender offer for approval by the shareholders at a general meeting of the company.’ Tender offer terms will be set out in a general meeting circular to come in due course.
----------
Halo Minerals PLC - owns Playa Verde copper tailings asset in Chile - Has contracted environmental consultancy firm MSTECK Spa, as well as team led by Maria Carolina Parodi Davila. Davila is head of the soil & environment laboratory at the Universidad Tecnologica Metropolitana in Santiago, Chile. ‘The team will conduct a comprehensive bio-accessibility and human health risk assessment study at Halo’s Playa Verde project site,’ Halo says. ‘The objective of the study is to support and verify that the planned development and operation of the Playa Verde project will not generate exposure levels that pose a risk to the health of the local population in accordance with the EIA approval.’
----------
Eden Research PLC - Oxfordshire, England-based developer of biopesticides and formulation technologies for the crop protection, animal health and consumer products industries - Partner Veto-pharma gets regulatory approval from the US Environmental Protection Agency for the use of Thymolflex in the management of Varroa, a parasitic mite that attacks and feeds on honey bees.
----------
Copyright 2026 Alliance News Ltd. All Rights Reserved.